Review article · 2026 · Open access

Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics

Jiaxin Li, Jianping Liu, Nan Wang, Keyi Zhang, Wen Zhang, Mengze Gao, Zhiguo Lu, Xiaoyuan Shawn Chen, Yan Li

Advanced Materials, e75408 · Published 18 October 2026 · DOI 10.1002/adma.75408

Open PDFView at the publisherCite this paper

In brief

“Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics” is a 2026 review article by Jiaxin Li and 8 co-authors, published in Advanced Materials. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Advanced Materials.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.50
References
204
Authors
9

Abstract

Lipid nanoparticles (LNPs) have transformed RNA therapeutics through their high delivery efficiency, scalable manufacturing, and favorable safety profiles, as demonstrated by COVID-19 mRNA vaccines and clinically approved small interfering RNA (siRNA) therapeutics. However, extending RNA delivery beyond the liver to extrahepatic tissues, including the spleen, lungs, lymph nodes, brain, and tumors, remains challenging because of the intrinsic hepatotropism of conventional LNPs and their limited cell-type specificity. Recent advances in lipid chemistry, particle engineering, surface functionalization, protein corona modulation, and route-specific administration have enabled new strategies to redirect LNPs toward specific tissues and cell populations. This review systematically examines these approaches and highlights key determinants of LNP tropism, including formulation composition, surface properties, endogenous protein adsorption, and administration route. We further discuss the clinical translation of extrahepatic LNP delivery, covering clinically validated products, emerging therapeutic candidates, and gaps between preclinical models and human applications. Major challenges include cell-resolved biodistribution, long-term safety, repeated-dose immunogenicity, cross-study comparability, and standardized quantitative assessment. Finally, we explore how high-throughput screening, machine learning, and data-driven design can accelerate the rational optimization of next-generation LNPs. These advances may facilitate precise tissue- and cell-selective RNA delivery, expanding the therapeutic potential of RNA medicines beyond the liver.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Li, J., Liu, J., Wang, N., Zhang, K., Zhang, W., Gao, M., Lu, Z., Chen, X. S., & Li, Y. (2026). Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics. Advanced Materials, e75408. https://doi.org/10.1002/adma.75408

MLA 9

Li, Jiaxin, et al. “Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics.” Advanced Materials, 2026, p. e75408. https://doi.org/10.1002/adma.75408.

Chicago

Li, Jiaxin, Jianping Liu, Nan Wang, Keyi Zhang, Wen Zhang, Mengze Gao, Zhiguo Lu, Xiaoyuan Shawn Chen, and Yan Li. 2026. “Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics.” Advanced Materials: e75408. https://doi.org/10.1002/adma.75408.

Harvard

Li, J. et al. (2026) ‘Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics’, Advanced Materials, p. e75408. doi:10.1002/adma.75408.

IEEE

J. Li et al., “Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics,” Advanced Materials, p. e75408, 2026, doi: 10.1002/adma.75408.

BibTeX

@article{li2026emerging,
  title     = {{Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics}},
  author    = {Li, Jiaxin and Liu, Jianping and Wang, Nan and Zhang, Keyi and Zhang, Wen and Gao, Mengze and Lu, Zhiguo and Chen, Xiaoyuan Shawn and Li, Yan},
  journal   = {Advanced Materials},
  year      = {2026},
  pages     = {e75408},
  doi       = {10.1002/adma.75408},
  url       = {https://doi.org/10.1002/adma.75408}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • RNA therapeutics
  • hepatotropism
  • siRNA delivery
  • mRNA vaccines
  • surface functionalization
  • protein corona
  • tissue distribution

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Li, J., Liu, J., Wang, N., Zhang, K., Zhang, W., Gao, M., Lu, Z., Chen, X. S., & Li, Y. (2026). Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics. Advanced Materials, e75408. https://doi.org/10.1002/adma.75408

How many times has this paper been cited?

1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Materials: sign in and open the PDF from this page.

Who wrote this paper?

Jiaxin Li, Jianping Liu, Nan Wang, Keyi Zhang, Wen Zhang, Mengze Gao, Zhiguo Lu, Xiaoyuan Shawn Chen, Yan Li.

What is the DOI of this paper?

10.1002/adma.75408, permanently at https://doi.org/10.1002/adma.75408. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.